When Project ALS decided to move prosetin to clinical trial independently, we were newcomers to drug development. Our first task: assembling a team of experts
Project ALS, along with the rest of the world, has faced serious headwinds this year—but we regrouped, focused our priorities, and have taken significant strides
The key to finding better drugs at the Project ALS Therapeutics Core at Columbia (THE CORE) is developing better pre-clinical laboratory models of ALS. A
MEET THE CORE: SUSAN BRENNER-MORTON Susan Brenner-Morton is an antibody expert who has spent decades developing these specialized tools to help us understand how motor
Project ALS presents TOMORROW IS TONIGHT A Virtual Celebration hosted by Richard Kind & Friends Thursday, October 22nd, 2020 • 7:30 PM Now more than
We’ve teamed up with Kilter Rewards for a virtual wellness challenge where YOU can help raise essential funding by staying active! Your participation will contribute
Five years ago, Raleigh, North Carolina’s own Chris Combs, a loving husband and father of three young children, was diagnosed out of nowhere with ALS.
Earlier this month, we reached a big regulatory milestone: Prosetin received Orphan Drug Designation, or orphan status, for the treatment of ALS from the Food
In our biweekly webinars, we have described the process of developing Prosetin—the first potential investigational drug to emerge from The Project ALS Therapeutics Core at
The Wasserman family has experienced first-hand the devastating effects of neurodegenerative diseases: Sandra Wasserman lost her beloved husband to Parkinson’s disease, and her son to
Last year, Project ALS launched The Project ALS Therapeutics Core at Columbia (THE CORE), a 3-year, $6.3M initiative toward the first meaningful therapies for ALS.
Project ALS is encouraged by the introduction of two bills that aim to provide people with ALS faster, more robust access to experimental therapies. These
NEW MAILING ADDRESS
2585 Broadway, Suite 202
New York, NY 10025
Phone: (212) 420-7382
Email: [email protected]
Copyright Project ALS 2025 | Built with by Edward Kado
